Thermo Fisher Scientific (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,151,000 | 3,133,000 | 3,482,000 | 8,524,000 | 2,919,000 |
| Receivables | 8,370,000 | 8,019,000 | 7,922,000 | 8,115,000 | 7,671,000 |
| Inventories | 5,404,000 | 5,655,000 | 5,664,000 | 5,634,000 | 5,722,000 |
| Other current assets | 3,167,000 | 3,188,000 | 3,141,000 | 2,956,000 | 2,987,000 |
| TOTAL | $23,092,000 | $19,995,000 | $20,209,000 | $25,229,000 | $19,299,000 |
| Non-Current Assets | |||||
| PPE Net | 9,167,000 | 9,292,000 | 9,354,000 | 9,280,000 | 8,628,000 |
| Intangibles | 60,674,000 | 60,710,000 | 61,112,000 | 58,638,000 | 58,301,000 |
| Other Non-Current Assets | 4,124,000 | 4,108,000 | 3,983,000 | 4,007,000 | 4,308,000 |
| TOTAL | $73,965,000 | $74,110,000 | $74,449,000 | $71,925,000 | $71,237,000 |
| Total Assets | $97,057,000 | $94,105,000 | $94,658,000 | $97,154,000 | $90,536,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,508,000 | 2,423,000 | 2,798,000 | 3,381,000 | 2,471,000 |
| Accrued Expenses | 1,460,000 | 1,310,000 | 1,307,000 | 2,095,000 | 1,864,000 |
| Other current liabilities | 2,547,000 | 2,590,000 | 2,662,000 | 2,601,000 | 2,567,000 |
| TOTAL | $14,158,000 | $14,112,000 | $15,884,000 | $17,010,000 | $11,118,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 30,489,000 | 29,194,000 | 29,135,000 | 28,909,000 | 28,150,000 |
| Other Non-Current Liabilities | 4,464,000 | 4,154,000 | 4,350,000 | 4,356,000 | 4,517,000 |
| TOTAL | $37,553,000 | $36,191,000 | $36,464,000 | $36,112,000 | $35,810,000 |
| Total Liabilities | $51,711,000 | $50,303,000 | $52,348,000 | $53,122,000 | $46,928,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 386,372 | 385,950 | 385,721 | 385,430 | 392,196 |
| Common Shares | 442,000 | 441,000 | 441,000 | 441,000 | 440,000 |
| Retained earnings | 45,869,000 | 44,289,000 | 43,064,000 | 41,910,000 | 40,452,000 |
| Other shareholders' equity | -3,009,000 | -2,874,000 | -3,001,000 | -3,045,000 | -2,869,000 |
| TOTAL | $45,346,000 | $43,802,000 | $42,310,000 | $44,032,000 | $43,608,000 |
| Total Liabilities And Equity | $97,057,000 | $94,105,000 | $94,658,000 | $97,154,000 | $90,536,000 |